0001415889-23-002604.txt : 20230215 0001415889-23-002604.hdr.sgml : 20230215 20230215163045 ACCESSION NUMBER: 0001415889-23-002604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shearman Mark S CENTRAL INDEX KEY: 0001643799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 23635782 MAIL ADDRESS: STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP STREET 2: 11801 RESEARCH DRIVE, SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 form4-02152023_040213.xml X0306 4 2023-02-13 0001650664 Editas Medicine, Inc. EDIT 0001643799 Shearman Mark S C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 false true false false EVP, CHIEF SCIENTIFIC OFFICER Common Stock 2023-02-13 4 S 0 2790 9.6653 D 65559 D Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. /s/ Mark Shearman 2023-02-15